ELTX Earnings

Quarterly EPS
$-1.39
Q3 2024
$-1.02
Q4 2024
$-0.87
Q1 2025
$-0.66
Q2 2025
$-0.60
Q3 2025
$-0.50
Q4 2025
$-0.65
Q1 2026
$-0.43
Q2 2026
Latest RevenueN/A
Latest Net Income-8217000
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2026-$0.430-8217000+34.8%
Q1 2026-$0.650-11823000+25.3%
Q4 2025-$0.500-7718000+51.0%
Q3 2025-$0.600-10083000+56.8%
Q2 2025-$0.660-10561000-3.1%
Q1 2025-$0.870-11209000+24.3%
Q4 2024-$1.020-14004000+1.9%
Q3 2024-$1.390-18838000-9.4%
Q2 2024-$0.640-7229000
Q1 2024-$1.150-11827000
Q4 2023-$1.040-8949000
Q3 2023-$1.270-10658000
Elicio Therapeutics (ELTX) — Earnings